Therapeutic decision based on molecular detection of resistance mechanism in an ALK-rearranged lung cancer patient: a case report

BACKGROUND: The use of tyrosine kinase inhibitors (TKIs) of ALK is the therapy of choice for ALK-fusion patients. Unfortunately, all patients under this kind of treatment eventually develop acquired resistance through several well-known mechanisms, such as acquisition of a secondary mutation within...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Onco Targets Ther
Glavni autori: De Carlo, Elisa, Schiappacassi, Monica, Urbani, Martina, Doliana, Roberto, Baldassarre, Gustavo, Da Ros, Valentina, Santarossa, Sandra, Chimienti, Emanuela, Berto, Eleonora, Fratino, Lucia, Bearz, Alessandra
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2018
Teme:
Case Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6292407/
https://ncbi.nlm.nih.gov/pubmed/30573982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S184745
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items